modifying agent
Rapped method for determination of lead in brine water samples by cloud point extraction prior to FAAS by using modifying agent
... A cloud point extraction (CPE) method was developed for the separation and preconcentration of trace amounts of lead using flame atomic absorption spectrometry (FAAS) to determine trace amounts of lead in brinewater. The ...
5
TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
... Treatment of multiple sclerosis (MS) is challenging: disease-modifying treatments (DMTs) must both limit unwanted immune responses associated with disease initiation and propagation (as T and B lymphocytes are ...
6
<p>A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca</p>
... Abstract: Keratoconjunctivitis sicca (KCS) is a multifactorial disease characterized by tear hyperosmolarity, in fl ammation, and ocular surface damage. Cyclosporine A (CsA) is used as an effective ...
9
Vaginal transmission of cell associated HIV 1 in the mouse is blocked by a topical, membrane modifying agent
... Using the HuPBL-SCID model of vaginal transmission, we have identified a candidate agent that is highly effec- tive in interrupting vaginal transmission of cell-associat- ed HIV-1. Application of β -CD to the ...
8
Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US
... Background: The US Food and Drug Administration has issued warnings about a potential link between leukotriene receptor-modifying agents (LTMA) and suicide. These warnings are based on case reports and there is ...
6
Fabrication of hydrophilic silica coating varnish on pineapple peel fiber based biocomposite
... the modifying agent into commercial beeswax varnish with various mixing ratios, under homogenous ...(modifying agent: beeswax varnish percentage): 0:100, 40:60, 60:40 and ...
6
EVALUATION OF COMPATIBILITY BETWEEN DICLOFENAC SODIUM, ISOLATED NOVEL FICUS PALMATA MUCILAGE AND SOME OTHER PHARMACEUTICAL EXCIPIENTS
... Plants are non-polluting resources for sustainable supply of economic pharmaceutical excipients or products. New and improved excipients continue to be developed to meet the requirements of drug delivery systems in ...
8
Perturbing Gangliosides In-vitro Using Ambroxol as a Treatment for Neurodegeneration
... ganglioside modifying agent that has been shown to perturb enzymes in the ganglioside degradation pathway, in order to determine if Ambroxol has any effects on neuronal ganglioside expression profiles, and ...
105
Studies on Self Compacting Concrete
... viscosity modifying agent also acts as an admixture, this combination will result in very lower stability, hence any powdery material has to be added, and this study deals with replacement of cement by Fly ...
5
Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm
... disease-modifying agent, kinetically stabilizes mutant TTR tetramers and prevents their dissociation into monomers, which is a critical, rate-limiting step in fi- bril formation and amyloidogenesis [1, ...
17
A formula-driven scalable benchmark model for ABM, applied to FLAME GPU
... Rousset et al. [7] used their reference model [8] to benchmark 10 existing platforms that support parallel and distributed systems. The reference model they used is based on three main behaviours for each agent: ...
13
Intelligent graphite core condition monitoring
... Figure 5 shows how the analysis can be encapsulated in an agent, for the particular case of comparing refuelling records with anomalous channel power discrepancies. The analysis is performed as soon as the data ...
8
Multi-agents Systems for Remote Control on Internet
... “Media” agent communicates with the camera in order to broadcast signals (video, images) of the mobile robot in its ...Selection Agent) and a reactive ...(Perception Agent) and the effectors (Action ...
6
Upadacitinib improves patient reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease modifying antirheumatic drugs: results from SELECT NEXT
... AM: Morning; bDMARD: Biologic disease-modifying antirheumatic drug; BP: Bodily pain; CI: Confidence interval; csDMARD: Conventional synthetic disease-modifying antirheumatic drug; CCP: Cyclic citrullinated ...
11
An Improved Contract Net Protocol with Multi Agent for Reservoir Flood Control Dispatch
... cooperated Agent receives the bid parameter of reservoir dispatcher Agent, because there are the differ- ent dimension parameters for the lowest water level and the lowest water temperature in the water ...
12
Early combination disease modifying antirheumatic drug therapy and tight disease control improve long term radiologic outcome in patients with early rheumatoid arthritis: the 11 year results of the Finnish Rheumatoid Arthritis Combination Therapy trial
... Abbreviations CI: confidence interval; DMARD: disease-modifying antirheumatic drug; FINRACo: study group treated for the first 2 years with a combination of three disease-modifying antir[r] ...
8
Modifying an Agent-Based Method of Disturbance Handling with Alternative Techniques of Learning
... the agent of its own decision making ...multi agent environment can help agents to improve their ...when agent adapt to information about the environment and ...
8
Survey on Key Technologies in Cloud Workflow System Integration
... Muti Agent(MAS),designed interface agent based on reflective factory pattern, defined paramters of quality of service (QoS) in cloud workflow system and gived QoS’s estimation mode of ...
7
Design and Development of a Platform for Processing Bio-Images and Signals Using Agent Oriented Programming
... Use cases are an effective way to capture the potential functional requirements of a new system. Each use case presents one or more scenarios that demonstrate how the system should interact with the end user or another ...
11
Impact of telmisartan in modifying vascular risk
... The beneficial role of RAAS inhibition in the secondary prevention of CV and renal diseases, and in patients with diabetes at high CV risk, has been clearly demonstrated. However, what[r] ...
9